We are live on ! Find out more
SA

Sovran Advisors Portfolio holdings

AUM $1.34B
1-Year Est. Return 21.63%
This Fund
S&P 500
This Quarter Est. Return
-2.44%
1 Year Est. Return
+21.63%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$770M
AUM Growth
+$68.8M
Cap. Flow
+$130M
Cap. Flow %
16.87%
Top 10 Hldgs %
19.85%
Holding
481
New
73
Increased
256
Reduced
119
Closed
26
Avg Time Held
0.8 quarters
Top 10 Avg Time Held
0.8 quarters
Top 20 Avg Time Held
0.9 quarters

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$7.21M
2
AAPL icon
Apple
AAPL
+$6.33M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$5.14M
4
MSFT icon
Microsoft
MSFT
+$5M
5
META icon
Meta Platforms (Facebook)
META
+$4.68M

Sector Composition

Rank Sector Weight
1 Miscellaneous 72.84%
2 Technology 9.26%
3 Healthcare 4.68%
4 Consumer Discretionary 3.53%
5 Financials 2.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SKOR icon
476
Northern Trust Credit-Scored US Corporate Bond ETF
SKOR
$1B
– –
-6,612
Closed -$313K –
SLB icon
477
SLB Ltd
SLB
$72.4B
– –
-63,847
Closed -$2.55M –
SWAN icon
478
Amplify BlackSwan Growth & Treasure Core ETF
SWAN
$153M
– –
-8,578
Closed -$247K –
TT icon
479
Trane Technologies
TT
$105B
– –
-526
Closed -$201K –
UPS icon
480
United Parcel Service
UPS
$80.6B
– –
-5,239
Closed -$659K –

Similar funds

Sovran Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Sovran Advisors held 481 positions worth $770M, up 9.8% from $702M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Sovran Advisors deployed $130M of net new capital in Q1 2025, opening 73 new positions and adding to 256 existing holdings. Its largest new stake was Novo Nordisk: 36,559 shares worth $2.12M.

By sector, the portfolio is most concentrated in Miscellaneous at 73% of assets, down from 75% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was PIMCO Dynamic Income Fund, an estimated $2.67M trimmed.

  • Sovran Advisors's largest Q1 2025 buy was Novo Nordisk: 36,559 shares worth $2.12M.
  • Sovran Advisors added most to Qualcomm in Q1 2025, an estimated $7.21M increase.
  • Sovran Advisors's biggest Q1 2025 reduction was PIMCO Dynamic Income Fund, cutting an estimated $2.67M.
  • Sovran Advisors fully exited Celldex Therapeutics in Q1 2025, selling an estimated $2.6M.
  • Sovran Advisors's ten largest holdings make up 20% of its $770M portfolio in Q1 2025.
  • Sovran Advisors opened 73 new positions and closed 26 in Q1 2025.
  • Sovran Advisors's portfolio value rose 9.8% quarter-over-quarter to $770M.

Based on Sovran Advisors's 13F filing for Q1 2025, filed 25 Apr 2025.